Kowal Investment Group’s Encompass Health EHC Stock Holding History

Kowal Investment Group’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-77	Closed	-$5K	–	354
2021 Q3	$5K	Buy	+77	New	+$4.84K	﹤0.01%	637

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kowal Investment Group's EHC Position: Q4 2021 in Review

Kowal Investment Group sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 77 shares — an estimated $5K sold.

Kowal Investment Group first reported a position in EHC in Q3 2021 and held it in 1 quarter. The position peaked at $5K in Q3 2021. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

Kowal Investment Group reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 77 Encompass Health shares in Q4 2021, an estimated $5K.
Kowal Investment Group first reported a position in Encompass Health in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Encompass Health position peaked at $5K in Q3 2021.
409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.